268 related articles for article (PubMed ID: 18930672)
1. Retrospective analysis of children with uveitis treated with infliximab.
Tugal-Tutkun I; Ayranci O; Kasapcopur O; Kir N
J AAPOS; 2008 Dec; 12(6):611-3. PubMed ID: 18930672
[TBL] [Abstract][Full Text] [Related]
2. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
3. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
Simonini G; Zannin ME; Caputo R; Falcini F; de Martino M; Zulian F; Cimaz R
Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
[TBL] [Abstract][Full Text] [Related]
4. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
[TBL] [Abstract][Full Text] [Related]
6. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.
Suhler EB; Smith JR; Giles TR; Lauer AK; Wertheim MS; Kurz DE; Kurz PA; Lim L; Mackensen F; Pickard TD; Rosenbaum JT
Arch Ophthalmol; 2009 Jun; 127(6):819-22. PubMed ID: 19506209
[No Abstract] [Full Text] [Related]
7. Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Januschowski K; Voykov B; Deuter C
Br J Ophthalmol; 2014 Apr; 98(4):523-8. PubMed ID: 24457365
[TBL] [Abstract][Full Text] [Related]
8. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
Sobrin L; Kim EC; Christen W; Papadaki T; Letko E; Foster CS
Arch Ophthalmol; 2007 Jul; 125(7):895-900. PubMed ID: 17620567
[TBL] [Abstract][Full Text] [Related]
9. Infliximab and adalimumab for uveitis.
Martel JN; Esterberg E; Nagpal A; Acharya NR
Ocul Immunol Inflamm; 2012 Feb; 20(1):18-26. PubMed ID: 22324897
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.
Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669
[TBL] [Abstract][Full Text] [Related]
11. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
Suhler EB; Smith JR; Wertheim MS; Lauer AK; Kurz DE; Pickard TD; Rosenbaum JT
Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
Farvardin M; Afarid M; Mehryar M; Hosseini H
Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
[TBL] [Abstract][Full Text] [Related]
14. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.
Ardoin SP; Kredich D; Rabinovich E; Schanberg LE; Jaffe GJ
Am J Ophthalmol; 2007 Dec; 144(6):844-849. PubMed ID: 17953940
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
16. Favorable response to high-dose infliximab for refractory childhood uveitis.
Kahn P; Weiss M; Imundo LF; Levy DM
Ophthalmology; 2006 May; 113(5):860-4.e2. PubMed ID: 16545455
[TBL] [Abstract][Full Text] [Related]
17. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab in the therapy of uveitis in childhood.
Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor-α therapy in uveitis.
Cordero-Coma M; Sobrin L
Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
